An Innovative Health Literacy Approach Designed to Improve Patient Understanding of Medication Labeling.

Area of Science:

• Health communication
• Patient education
• Drug labeling

Background:

• Limited health literacy poses a significant barrier to understanding essential medication information.
• Patient Package Inserts (PPIs) are critical but often challenging for patients to comprehend.
• Optimizing PPIs is vital for safe and effective medication use.

Purpose of the Study:

• To present an innovative methodology for enhancing patient understanding of medication labeling.
• To apply evidence-based health literacy principles to optimize PPI content.
• To use the bezlotoxumab PPI as a case study for this methodology.

Main Methods:

• A mixed-model, iterative approach involving content development, focus group testing, and comprehension testing.
• Content development guided by health literacy principles through industry-academia collaboration.
• Testing involved diverse populations, including those with limited health literacy identified via validated tools (NVS, Single Item Literacy Screener).

Main Results:

• Focus groups provided favorable feedback on organization, usability, language, and information volume.
• The revised bezlotoxumab PPI achieved high average comprehension scores: 96% overall, 90% for limited health literacy, and 97% for adequate health literacy.
• The methodology proved effective across diverse therapeutic areas, with comprehension scores ≥86% in a larger cohort (n=1197).

Conclusions:

• The developed methodology significantly advances the creation of understandable patient medication labeling.
• This approach is particularly beneficial for improving comprehension among individuals with limited health literacy.
• Enhanced PPIs contribute to better patient understanding and potentially improved health outcomes.